Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
International Journal of Hematology|June 11, 2010
Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcomaMinako Mori, Akiko Matsushita, Yohko Takiuchi, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 6, 2011
[Signet ring cell carcinoma of the bile duct: a case report]Tomonori Matsumoto, Satoko Inoue, Kenji Masuo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2012
How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations?Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, et al.Journal of Clinical and Experimental Hematopathology : JCEH|November 23, 2011
Enteropathy-associated T-cell lymphoma type II complicated by autoimmune hemolytic anemiaAiko Kato, Yoko Takiuchi, Kazunari Aoki, et al.Clinical Rheumatology|March 16, 2010
Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritisDaichi Inoue, Hiroshi Arima, Chiharu Kawanami, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2017
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort StudyShunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 11, 2010
[Therapeutic efficacy of cyclosporin A for refractory angioimmunoblastic T cell lymphoma]Minako Mori, Daichi Inoue, Hiroshi Arima, et al.International Journal of Clinical Oncology|March 11, 2010
Hepatosplenic alphabeta T cell lymphomaYuya Nagai, Kazuhiro Ikegame, Minako Mori, et al.Scientific Reports|September 14, 2017
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patientsDaichi Fujimoto, Keiichiro Uehara, Yuki Sato, et al.BMC Cancer|November 16, 2016
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinomaYuki Sato, Daichi Fujimoto, Keiichiro Uehara, et al.Pageof 16